The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

Share Price Information for Science Sprt (SIS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.75
Bid: 15.50
Ask: 16.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.226%)
Open: 15.75
High: 15.75
Low: 15.75
Prev. Close: 15.75
SIS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SIS granted patent for novel WHEY20

30 May 2017 07:00

RNS Number : 4772G
Science in Sport PLC
30 May 2017
 

For immediate release

30th May 2017

 

SCIENCE IN SPORT PLC

("SiS" or the "Company")

 

SIS granted patent for novel WHEY20

 

Science in Sport plc (AIM: SIS), a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts, is pleased to announce it has received a Certificate of Grant of Patent for WHEY20 reflecting the unique features and benefits of the product.

 

SiS launched its novel WHEY20 protein gel ('WHEY20') in January 2016, which helps athletes' maintain muscle mass and can also promote muscle growth. Sales of WHEY20 have been ahead of forecast in the first year and this year sees a relaunch with two new flavours.

 

The production of WHEY20 required several technical challenges to be overcome and marks a significant breakthrough in the creation of a ready-to consume high-quality protein.  WHEY20's unique composition provides consumers with a portable, highly concentrated source of whey protein (20g) that does not require refrigeration. These unique features give WHEY20 widespread appeal in the sports and health and gym markets.

 

Whey protein is central to the WHEY20 formulation as this protein is rich in essential amino acids, especially the branched chain amino acids (BCAAs). The composition of whey protein is almost identical to muscle tissue, this makes it the ideal protein source for athletes who wish to maintain muscle tissue, or increase muscle mass .

 

Several gels on the market contain collagen. This has a very different amino acid content to human muscle and is nutritionally inferior to whey protein. Most existing whey protein products on the market are powders, which have to be mixed by the consumer. Some ready to drink products provide a convenient source of whey protein, but often require refrigeration and invariably they have a lower whey protein content than WHEY20.

 

SiS Chief Executive Stephen Moon commented:

 

"Science and innovation underpins everything we do and we are delighted to continue to be at the cutting edge of developments in sports science and the manufacturing process of products, whilst building a portfolio of patents. We have a very strong innovation pipeline for 2017 onwards, continuing to work on further innovation to fuel professional athletes and sports enthusiasts."

 

 

For further information:

 

 

Science in Sport PLC

 

+44 (0) 20 7400 3700

 

Stephen Moon, CEO

 

 

Elizabeth Lake, Finance Director

 

 

 

Cenkos Securities - NOMAD and Broker

 

+44 (0) 20 7397 8900

 

Bobbie Hilliam

 

 

 

 

 

 

Yellow Jersey PR - Financial PR

 

 

Felicity Winkles

+44 (0) 7748 843 871

 

Harriet Jackson

+44 (0) 7544 275 882

 

 

Notes for editors

 

About Science in Sport plc

 

Science in Sport plc is a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts. SiS is a strong brand in the elite athlete community - in the 2016 Rio Olympics, 34 medal-winning athletes or teams used SiS products (compared with 24 in 2012).

 

The SiS core product ranges include: SiS GO, comprising energy powders, isotonic gels, energy bars and hydration tablets; SiS REGO, including protein-based recovery powders and bars; and SIS Protein, products specifically designed to contribute to athletes' lean muscle mass growth and maintenance. SiS products are sold in a range of retail channels, including specialist sport retailers, major grocers, high street retailers and e-commerce websites.

 

SiS is currently the official sports nutrition supplier to professional cycling team Team SKY, British Cycling and USA Cycling. SiS is also the official sports nutrition partner to Liverpool FC. In addition, Olympians Sir Chris Hoy MBE, and Katarina Johnson Thomson are Brand Ambassadors and Mark Cavendish MBE is an Elite Sports Consultant to the brand.

 

SiS was founded in 1992 and is headquartered in Hatton Garden, London. Its manufacturing facility is in Nelson, Lancashire.

 

SiS shares are traded on the AIM market of the London Stock Exchange under the ticker symbol SIS.

 

For further information, please visit www.scienceinsport.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABKLLLDEFFBBE
Date   Source Headline
6th Mar 20247:00 amRNSTrading Update
5th Jan 20247:00 amRNSDirector/PDMR Shareholding
5th Jan 20247:00 amRNSNotification of Major Holdings
29th Dec 202311:20 amRNSIssue of Equity and Total Voting Rights
19th Oct 20237:00 amRNSDirectorate Change
16th Oct 20237:00 amRNSBoard Changes
28th Sep 202310:30 amRNSInterim Results - Replacement
28th Sep 20237:00 amRNSAppointment of Non Exec Chairman
28th Sep 20237:00 amRNSInterim Results
28th Jul 20232:58 pmRNSResult of Annual General Meeting
28th Jul 20237:00 amRNSBoard changes
10th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20233:49 pmRNSTR-1: Notification of Major Holdings
5th Jul 20237:00 amRNSBoard Change and Notice of AGM
4th Jul 20237:30 amRNSRestoration - Science in Sport PLC
4th Jul 20237:00 amRNSRestoration of Trading & Posting of Annual Report
3rd Jul 20237:30 amRNSSuspension - Science In Sport Plc
3rd Jul 20237:00 amRNSTemporary Suspension
29th Jun 202310:38 amRNSReplacement RNS - Preliminary Results
29th Jun 20237:00 amRNSFinal results
28th Jun 202310:43 amRNSNotification of Major Holdings
23rd Jun 20237:00 amRNSNotice of Final Results
2nd May 20233:33 pmRNSAIM Rule 17 / Schedule 2(g) Update
18th Apr 20237:00 amRNSInvestor Site Visit
13th Apr 202312:23 pmRNSForm 8.3 - Science In Sport Plc
13th Apr 202312:06 pmRNSForm 8.3 - Science in Sport PLC
13th Apr 20238:34 amRNSForm 8.5 (EPT/RI)
13th Apr 20237:00 amRNSConclusion of Strategic Review and Trading Update
12th Apr 20239:06 amRNSForm 8.5 (EPT/RI)
11th Apr 20232:54 pmRNSForm 8.3 - Science In Sport Plc
11th Apr 202312:17 pmRNSForm 8.3 - Science in Sport PLC
11th Apr 20239:22 amRNSForm 8.5 (EPT/RI)
11th Apr 20237:00 amRNSForm 8.3 - Science in Sport PLC
6th Apr 20236:17 pmRNSForm 8.3 - SCIENCE IN SPORT PLC
6th Apr 20232:52 pmRNSForm 8.3 - [Science in Sport plc]
5th Apr 20238:22 amRNSForm 8.5 (EPT/RI)
3rd Apr 20232:29 pmRNSForm 8.3 - [Science in Sport plc]
3rd Apr 20239:20 amRNSForm 8.5 (EPT/RI)
30th Mar 20238:50 amRNSForm 8.5 (EPT/RI)
29th Mar 202311:58 amRNSForm 8.3 - Science in Sport Plc
29th Mar 20238:42 amRNSForm 8.5 (EPT/RI)
28th Mar 20239:57 amRNSForm 8.3 - Science in Sport Plc
28th Mar 20239:52 amRNSForm 8.5 (EPT/RI) - Science in Sport PLC
27th Mar 202312:31 pmRNSForm 8.3 - Science in Sport PLC
27th Mar 202312:29 pmRNSForm 8.3 - Science in Sport Plc
23rd Mar 202311:01 amRNSForm 8.3 - Science in Sport PLC
23rd Mar 202310:54 amRNSForm 8.3 - Science in Sport PLC
23rd Mar 20238:43 amRNSForm 8.5 (EPT/RI)
22nd Mar 20235:55 pmRNSForm 8.3 - Science in Sport PLC
22nd Mar 20231:15 pmRNSForm 8.3 - Science in Sport plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.